Literature DB >> 19335813

Treatment of cutaneous leishmaniasis in travelers 2009.

Johannes A Blum1, Christoph F Hatz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19335813     DOI: 10.1111/j.1708-8305.2008.00286.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


× No keyword cloud information.
  14 in total

Review 1.  Leishmaniasis in the United States: treatment in 2012.

Authors:  Henry W Murray
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Successful treatment of Old World cutaneous leishmaniasis caused by Leishmania infantum with posaconazole.

Authors:  A E Paniz Mondolfi; C Stavropoulos; T Gelanew; E Loucas; A M Perez Alvarez; G Benaim; B Polsky; G Schoenian; E M Sordillo
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

3.  Cutaneous leishmaniasis in a returning traveller.

Authors:  Eric Demers; David M Forrest; Gabriele E Weichert
Journal:  CMAJ       Date:  2013-03-25       Impact factor: 8.262

4.  Multilesional cutaneous leishmaniasis.

Authors:  Yuval Ramot; Abraham Zlotogorski
Journal:  CMAJ       Date:  2016-05-16       Impact factor: 8.262

5.  Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis.

Authors:  Yavuz Yesilova; Hacer Altın Surucu; Nurittin Ardic; Mustafa Aksoy; Abdullah Yesilova; Steve Oghumu; Abhay R Satoskar
Journal:  J Dermatolog Treat       Date:  2015-06-24       Impact factor: 3.359

6.  Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment.

Authors:  V Mosimann; A Neumayr; C Hatz; J A Blum
Journal:  Infection       Date:  2013-07-09       Impact factor: 3.553

Review 7.  Human African trypanosomiasis in endemic populations and travellers.

Authors:  J A Blum; A L Neumayr; C F Hatz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-07       Impact factor: 3.267

8.  Case report: Successful treatment of cutaneous leishmaniasis caused by Leishmania aethiopica with liposomal amphothericin B in an immunocompromised traveler returning from Eritrea.

Authors:  Philipp Zanger; Ina Kötter; Armin Raible; Tesfaye Gelanew; Gabriele Schönian; Peter G Kremsner
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

9.  Dermatologic presentations of tropical diseases in travelers.

Authors:  Gentiane Monsel; Eric Caumes
Journal:  Curr Infect Dis Rep       Date:  2010-05       Impact factor: 3.663

10.  Easy identification of leishmania species by mass spectrometry.

Authors:  Oussama Mouri; Gloriat Morizot; Gert Van der Auwera; Christophe Ravel; Marie Passet; Nathalie Chartrel; Isabelle Joly; Marc Thellier; Stéphane Jauréguiberry; Eric Caumes; Dominique Mazier; Carine Marinach-Patrice; Pierre Buffet
Journal:  PLoS Negl Trop Dis       Date:  2014-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.